Search by Drug Name or NDC

    NDC 67877-0584-05 CEFIXIME 400 mg/1 Details

    CEFIXIME 400 mg/1

    CEFIXIME is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is CEFIXIME.

    Product Information

    NDC 67877-0584
    Product ID 67877-584_30690cba-b831-45c1-b799-a013d6cfc2db
    Associated GPIs 02300060000120
    GCN Sequence Number 028142
    GCN Sequence Number Description cefixime CAPSULE 400 MG ORAL
    HIC3 W1Y
    HIC3 Description CEPHALOSPORIN ANTIBIOTICS - 3RD GENERATION
    GCN 33118
    HICL Sequence Number 003999
    HICL Sequence Number Description CEFIXIME
    Brand/Generic Generic
    Proprietary Name CEFIXIME
    Proprietary Name Suffix n/a
    Non-Proprietary Name CEFIXIME
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 400
    Active Ingredient Units mg/1
    Substance Name CEFIXIME
    Labeler Name Ascend Laboratories, LLC
    Pharmaceutical Class Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210574
    Listing Certified Through 2024-12-31

    Package

    NDC 67877-0584-05 (67877058405)

    NDC Package Code 67877-584-05
    Billing NDC 67877058405
    Package 500 CAPSULE in 1 BOTTLE (67877-584-05)
    Marketing Start Date 2018-10-12
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 6f1df975-f825-4301-87da-d7eba56a6890 Details

    Revised: 5/2022